Skip to main content
Caplight Logo









Genotypic Technology

Genotypic Technology

Private
Bangalore UrbanHealthcare & Life Scienceshttps://genotypic.co.in/

Last Round

Angel

Mar 31, 2006

Total Funding Raised

$171,000

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Genotypic Technology is a biotechnology company that provides genomics, bioinformatics, and molecular diagnostic services to pharmaceutical, biotech, and academic organizations.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Biotech Equipment, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales, Data as a Service

AI Layer

Application

Keywords

next-generation sequencingNGSbioinformaticsgenomic analysisprecision medicinemulti-omicsgenomics platformvariant callinghigh-performance computingHPCmolecular biologybiotech lab servicesgenomics as a serviceAI-driven genomicsbioinformatics pipelinedrug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Genotypic Technology Comparables

Compare Genotypic Technology with similar companies based on industry and business-model similarity.

Genotypic Technology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
SciGenom Labs
86%
Nucleome Informatics Private Limited
83%
Clevergene
83%

Genotypic Technology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AngelMar 31, 2006

Key People

Founding team and executive leadership

Raja Mugasimangalam

Founder and CEO

Founding Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors grew 53% MoM, from 1.5K to 2.3K.

  • Jan 19, 2026

    Monthly visitors grew 273% MoM, reaching 6.3K.

Genotypic Technology Filings

Explore SEC and related filing metadata, where available.

Genotypic Technology filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Genotypic Technology's valuation, stock price, and market status.

Is Genotypic Technology a public or private company?

Genotypic Technology is a private company.

What is the current stock price of Genotypic Technology?

Genotypic Technology is a private company with no public stock price. No recent secondary market data is available.

How much is Genotypic Technology worth (valuation)?

Valuation information for Genotypic Technology is not publicly available.

Can I buy Genotypic Technology stock?

Genotypic Technology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Genotypic Technology's last funding round?

Genotypic Technology's most recent funding round was Angel on March 31, 2006.

Who are the main investors in Genotypic Technology?

Investor information for Genotypic Technology is not publicly disclosed.

Will Genotypic Technology IPO soon?

No public IPO plans have been announced for Genotypic Technology.

How can I track Genotypic Technology secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Genotypic Technology's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBangalore Urban
Employee Range89
Year Founded1998
Last FundingMar 31, 2006

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?